Morgan Stanley Upgrades Doximity Citing Business Strength and AI Growth
Morgan Stanley upgraded Doximity to Overweight with a $65 target, citing stock underperformance vs. strong business checks and AI user growth. Barclays also initiated coverage with Overweight rating.